Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
VITFIT
- Development stage
- Unknown
- Lead developer
- Triman
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
VITFIT is a nutritional supplement manufactured by Triman, an Indonesian pharmaceutical company. The product primarily contains 500 mg of Vitamin C (ascorbic acid) per tablet. Vitamin C is an essential water-soluble nutrient that functions as a potent antioxidant and a necessary cofactor for several enzymatic reactions. It plays a critical role in collagen synthesis, tissue repair, and the production of certain neurotransmitters. VITFIT is indicated for maintaining immune health and preventing or treating Vitamin C deficiency.
- Brand names
- VITFIT
- Other names
- Vitamin Cascorbic acid
Beyond the preview
Go deeper on VITFIT.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on VITFIT.